A novel role of the aryl hydrocarbon receptor (AhR) in centrosome amplification - implications for chemoprevention

Molecular Cancer

Volumn 9, Issue , 2010, Pages

  Korzeniewski, Nina ^a,b   Wheeler, Sarah ^b   Chatterjee, Payel ^a   Duensing, Anette ^a,b   Duensing, Stefan ^a,b  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 METHYL 6 BROMOINDIRUBIN 3' OXIME; 1 METHYLINDIRUBIN 3' OXIME; 6 BROMOINDIRUBIN 3' ACETOXIME; 6 BROMOINDIRUBIN 3' OXIME; ANTINEOPLASTIC AGENT; AROMATIC HYDROCARBON RECEPTOR; CYCLIN E; INDIRUBIN 3' OXIME; UNCLASSIFIED DRUG; SMALL INTERFERING RNA;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CENTRIOLE; CENTROSOME; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DRUG POTENCY; HUMAN; HUMAN CELL; IC 50; PROTEIN EXPRESSION; PROTEIN FUNCTION; BREAST TUMOR; FEMALE; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

BREAST NEOPLASMS; CELL LINE, TUMOR; CENTROSOME; CHEMOPREVENTION; FEMALE; HUMANS; RECEPTORS, ARYL HYDROCARBON; RNA, SMALL INTERFERING;

EID: 77953562078     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-9-153     Document Type: Article

References (49)

1. Marlowe JL, Puga A. Aryl hydrocarbon receptor, cell cycle regulation, toxicity, and tumorigenesis. J Cell Biochem 2005, 96:1174-1184. 10.1002/jcb.20656, 16211578.
2. Schlezinger JJ, Liu D, Farago M, Seldin DC, Belguise K, Sonenshein GE, Sherr DH. A role for the aryl hydrocarbon receptor in mammary gland tumorigenesis. Biol Chem 2006, 387:1175-1187. 10.1515/BC.2006.145, 16972784.
3. Koutros S, Berndt SI, Sinha R, Ma X, Chatterjee N, Alavanja MC, Zheng T, Huang WY, Hayes RB, Cross AJ. Xenobiotic metabolizing gene variants, dietary heterocyclic amine intake, and risk of prostate cancer. Cancer Res 2009, 69:1877-1884. 10.1158/0008-5472.CAN-08-2447, 2662592, 19223546.
4. Gluschnaider U, Hidas G, Cojocaru G, Yutkin V, Ben-Neriah Y, Pikarsky E. beta-TrCP inhibition reduces prostate cancer cell growth via upregulation of the aryl hydrocarbon receptor. PLoS One 5:e9060. 10.1371/journal.pone.0009060, 2816705, 20140206.
5. Trombino AF, Near RI, Matulka RA, Yang S, Hafer LJ, Toselli PA, Kim DW, Rogers AE, Sonenshein GE, Sherr DH. Expression of the aryl hydrocarbon receptor/transcription factor (AhR) and AhR-regulated CYP1 gene transcripts in a rat model of mammary tumorigenesis. Breast Cancer Res Treat 2000, 63:117-131. 10.1023/A:1006443104670, 11097088.
6. Yang X, Solomon S, Fraser LR, Trombino AF, Liu D, Sonenshein GE, Hestermann EV, Sherr DH. Constitutive regulation of CYP1B1 by the aryl hydrocarbon receptor (AhR) in pre-malignant and malignant mammary tissue. J Cell Biochem 2008, 104:402-417. 10.1002/jcb.21630, 18059014.
7. Abdelrahim M, Smith R, Safe S. Aryl hydrocarbon receptor gene silencing with small inhibitory RNA differentially modulates Ah-responsiveness in MCF-7 and HepG2 cancer cells. Mol Pharmacol 2003, 63:1373-1381. 10.1124/mol.63.6.1373, 12761348.
8. Andersson P, McGuire J, Rubio C, Gradin K, Whitelaw ML, Pettersson S, Hanberg A, Poellinger L. A constitutively active dioxin/aryl hydrocarbon receptor induces stomach tumors. Proc Natl Acad Sci USA 2002, 99:9990-9995. 10.1073/pnas.152706299, 126612, 12107286.
9. Puga A, Barnes SJ, Dalton TP, Chang C, Knudsen ES, Maier MA. Aromatic hydrocarbon receptor interaction with the retinoblastoma protein potentiates repression of E2F-dependent transcription and cell cycle arrest. J Biol Chem 2000, 275:2943-2950. 10.1074/jbc.275.4.2943, 10644764.
10. Harper JW. Chemical biology: a degrading solution to pollution. Nature 2007, 446:499-500. 10.1038/446499a, 17392771.
11. Knockaert M, Blondel M, Bach S, Leost M, Elbi C, Hager G, Nagy SR, Han D, Denison M, French M, et al. Indepedent actions on cyclin-dependent kinases and aryl hydrocarbon receptor mediate the antiproliferative effects of indirubins. Oncogene 2004, 23:4400-4412. 10.1038/sj.onc.1207535, 15077192.
12. Lambert L, Keyomarsi K. Cell cycle deregulation in breast cancer: insurmountable chemoresistance or Achilles' heel?. Adv Exp Med Biol 2007, 608:52-69. full_text, 17993232.
13. Spruck CH, Won KA, Reed SI. Deregulated cyclin E induces chromosome instability. Nature 1999, 401:297-300. 10.1038/45836, 10499591.
14. Fukasawa K. Oncogenes and tumour suppressors take on centrosomes. Nat Rev Cancer 2007, 7:911-924. 10.1038/nrc2249, 18004399.
15. Duensing A, Spardy N, Chatterjee P, Zheng L, Parry J, Cuevas R, Korzeniewski N, Duensing S. Centrosome overduplication, chromosomal instability, and human papillomavirus oncoproteins. Environ Mol Mutagen 2009,
16. Azimzadeh J, Bornens M. Structure and duplication of the centrosome. J Cell Sci 2007, 120:2139-2142. 10.1242/jcs.005231, 17591686.
17. Lingle WL, Lukasiewicz K, Salisbury JL. Deregulation of the centrosome cycle and the origin of chromosomal instability in cancer. Adv Exp Med Biol 2005, 570:393-421. full_text, 18727509.
18. Nigg EA. Origins and consequences of centrosome aberrations in human cancers. Int J Cancer 2006, 119:2717-2723. 10.1002/ijc.22245, 17016823.
19. Ganem NJ, Godinho SA, Pellman D. A mechanism linking extra centrosomes to chromosomal instability. Nature 2009, 460:278-282. 10.1038/nature08136, 2743290, 19506557.
20. Lingle WL, Barrett SL, Negron VC, D'Assoro AB, Boeneman K, Liu W, Whitehead CM, Reynolds C, Salisbury JL. Centrosome amplification drives chromosomal instability in breast tumor development. Proc Natl Acad Sci USA 2002, 99:1978-1983. 10.1073/pnas.032479999, 122305, 11830638.
21. Lingle WL, Lutz WH, Ingle JN, Maihle NJ, Salisbury JL. Centrosome hypertrophy in human breast tumors: implications for genomic stability and cell polarity. Proc Natl Acad Sci USA 1998, 95:2950-2955. 10.1073/pnas.95.6.2950, 19675, 9501196.
22. Lingle WL, Salisbury JL. Altered centrosome structure is associated with abnormal mitoses in human breast tumors. Am J Pathol 1999, 155:1941-1951. 1866918, 10595924.
23. Duensing A, Duensing S. Guilt by association? p53 and the development of aneuploidy in cancer. Biochem Biophys Res Commun 2005, 331:694-700. 10.1016/j.bbrc.2005.03.157, 15865924.
24. Duensing S. A tentative classification of centrosome abnormalities in cancer. Cell Biol Int 2005, 29:352-359. 10.1016/j.cellbi.2005.03.005, 15890539.
25. Parvin JD. The BRCA1-dependent ubiquitin ligase, gamma-tubulin, and centrosomes. Environ Mol Mutagen 2009, 50:649-653. 10.1002/em.20475, 19274767.
26. Li JJ, Weroha SJ, Lingle WL, Papa D, Salisbury JL, Li SA. Estrogen mediates Aurora-A overexpression, centrosome amplification, chromosomal instability, and breast cancer in female ACI rats. Proc Natl Acad Sci USA 2004, 101:18123-18128. 10.1073/pnas.0408273101, 539804, 15601761.
27. Schneeweiss A, Sinn HP, Ehemann V, Khbeis T, Neben K, Krause U, Ho AD, Bastert G, Kramer A. Centrosomal aberrations in primary invasive breast cancer are associated with nodal status and hormone receptor expression. Int J Cancer 2003, 107:346-352. 10.1002/ijc.11408, 14506732.
28. Duensing S, Duensing A, Lee DC, Edwards KM, Piboonniyom S, Manuel E, Skaltsounis L, Meijer L, Munger K. Cyclin-dependent kinase inhibitor indirubin-3'-oxime selectively inhibits human papillomavirus type 16 E7-induced numerical centrosome anomalies. Oncogene 2004, 23:8206-8215. 10.1038/sj.onc.1208012, 15378001.
29. Shaye A, Sahin A, Hao Q, Hunt K, Keyomarsi K, Bedrosian I. Cyclin E deregulation is an early event in the development of breast cancer. Breast Cancer Res Treat 2009, 115:651-659. 10.1007/s10549-008-0266-0, 19107593.
30. Korzeniewski N, Zheng L, Cuevas R, Parry J, Chatterjee P, Anderton B, Duensing A, Munger K, Duensing S. Cullin 1 functions as a centrosomal suppressor of centriole multiplication by regulating polo-like kinase 4 protein levels. Cancer Res 2009, 69:6668-6675. 10.1158/0008-5472.CAN-09-1284, 19679553.
31. Knockaert M, Blondel M, Bach S, Leost M, Elbi C, Hager GL, Nagy SR, Han D, Denison M, Ffrench M, et al. Independent actions on cyclin-dependent kinases and aryl hydrocarbon receptor mediate the antiproliferative effects of indirubins. Oncogene 2004, 23:4400-4412. 10.1038/sj.onc.1207535, 15077192.
32. Kawanishi M, Sakamoto M, Ito A, Kishi K, Yagi T. Construction of reporter yeasts for mouse aryl hydrocarbon receptor ligand activity. Mutat Res 2003, 540:99-105.
33. Adachi J, Mori Y, Matsui S, Takigami H, Fujino J, Kitagawa H, Miller CA, Kato T, Saeki K, Matsuda T. Indirubin and indigo are potent aryl hydrocarbon receptor ligands present in human urine. J Biol Chem 2001, 276:31475-31478. 10.1074/jbc.C100238200, 11425848.
34. Hinds PW, Mittnacht S, Dulic V, Arnold A, Reed SI, Weinberg RA. Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell 1992, 70:993-1006. 10.1016/0092-8674(92)90249-C, 1388095.
35. Piel M, Meyer P, Khodjakov A, Rieder CL, Bornens M. The respective contributions of the mother and daughter centrioles to centrosome activity and behavior in vertebrate cells. J Cell Biol 2000, 149:317-330. 10.1083/jcb.149.2.317, 2175166, 10769025.
36. Kim DW, Gazourian L, Quadri SA, Romieu-Mourez R, Sherr DH, Sonenshein GE. The RelA NF-kappaB subunit and the aryl hydrocarbon receptor (AhR) cooperate to transactivate the c-myc promoter in mammary cells. Oncogene 2000, 19:5498-5506. 10.1038/sj.onc.1203945, 11114727.
37. Duensing A, Liu Y, Spardy N, Bartoli K, Tseng M, Kwon JA, Teng X, Duensing S. RNA polymerase II transcription is required for human papillomavirus type 16 E7- and hydroxyurea-induced centriole overduplication. Oncogene 2007, 26:215-223. 10.1038/sj.onc.1209782, 2228273, 16819507.
38. Duensing A, Chin A, Wang L, Kuan SF, Duensing S. Analysis of centrosome overduplication in correlation to cell division errors in high-risk human papillomavirus (HPV)-associated anal neoplasms. Virology 2008, 372:157-164. 10.1016/j.virol.2007.10.030, 2267749, 18036631.
39. Duensing A, Liu Y, Tseng M, Malumbres M, Barbacid M, Duensing S. Cyclin-dependent kinase 2 is dispensable for normal centrosome duplication but required for oncogene-induced centrosome overduplication. Oncogene 2006, 25:2943-2949. 10.1038/sj.onc.1209310, 2225596, 16331279.
40. Duensing S, Duensing A, Crum CP, Munger K. Human papillomavirus type 16 E7 oncoprotein-induced abnormal centrosome synthesis is an early event in the evolving malignant phenotype. Cancer Res 2001, 61:2356-2360.
41. Hoessel R, Leclerc S, Endicott JA, Nobel MEM, Lawrie A, Tunnah P, Leost M, Damiens E, Marie D, Marko D, et al. Indirubin, the active constituent of a chinese antileukaemia medicine, inhibits cyclin-dependent kinases. Nat Cell Biol 1999, 1:60-67. 10.1038/9035, 10559866.
42. Duensing A, Liu Y, Perdreau SA, Kleylein-Sohn J, Nigg EA, Duensing S. Centriole overduplication through the concurrent formation of multiple daughter centrioles at single maternal templates. Oncogene 2007, 26:6280-6288. 10.1038/sj.onc.1210456, 2586811, 17438528.
43. Habedanck R, Stierhof YD, Wilkinson CJ, Nigg EA. The Polo kinase Plk4 functions in centriole duplication. Nat Cell Biol 2005, 7:1140-1146. 10.1038/ncb1320, 16244668.
44. Hasskarl J, Duensing S, Manuel E, Munger K. The helix-loop-helix protein ID1 localizes to centrosomes and rapidly induces abnormal centrosome numbers. Oncogene 2004, 23:1930-1938. 10.1038/sj.onc.1207310, 14755252.
45. Hasskarl J, Mern DS, Munger K. Interference of the dominant negative helix-loop-helix protein ID1 with the proteasomal subunit S5A causes centrosomal abnormalities. Oncogene 2008, 27:1657-1664. 10.1038/sj.onc.1210808, 17891176.
46. Ohtake F, Baba A, Takada I, Okada M, Iwasaki K, Miki H, Takahashi S, Kouzmenko A, Nohara K, Chiba T, et al. Dioxin receptor is a ligand-dependent E3 ubiquitin ligase. Nature 2007, 446:562-566. 10.1038/nature05683, 17392787.
47. Tlsty TD, Crawford YG, Holst CR, Fordyce CA, Zhang J, McDermott K, Kozakiewicz K, Gauthier ML. Genetic and epigenetic changes in mammary epithelial cells may mimic early events in carcinogenesis. J Mammary Gland Biol Neoplasia 2004, 9:263-274. 10.1023/B:JOMG.0000048773.95897.5f, 15557799.
48. Zhang S, Lei P, Liu X, Li X, Walker K, Kotha L, Rowlands C, Safe S. The aryl hydrocarbon receptor as a target for estrogen receptor-negative breast cancer chemotherapy. Endocr Relat Cancer 2009, 16:835-844. 10.1677/ERC-09-0054, 19447902.
49. Duensing A, Spardy N, Chatterjee P, Zheng L, Parry J, Cuevas R, Korzeniewski N, Duensing S. Centrosome overduplication, chromosomal instability, and human papillomavirus oncoproteins. Environ Mol Mutagen 2009, 50:741-747. 10.1002/em.20478, 19326465.